Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Legality  





2 References  














6-(2-Aminopropyl)indole






Српски / srpski
Srpskohrvatski / српскохрватски
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 

(Redirected from 6-IT)

6-(2-Aminopropyl)indole
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • DE: Uncontrolled[1]
  • Uncontrolled (but covered under the Federal Analogue Act in the United States and Australia and likely under similar bills in other countries[clarification needed])[citation needed]
  • Identifiers
    • 1-(1H-Indol-6-yl)propan-2-amine

    CAS Number
    PubChem CID
    ChemSpider
    UNII
    CompTox Dashboard (EPA)
    Chemical and physical data
    FormulaC11H14N2
    Molar mass174.247 g·mol−1
    3D model (JSmol)
    • C1=C2C(=CC=C1CC(C)N([H])[H])C=C[N]2[H]

    • InChI=1S/C11H14N2/c1-8(12)6-9-2-3-10-4-5-13-11(10)7-9/h2-5,7-8,13H,6,12H2,1H3 checkY

    • Key:QCFIFKAOUKPFPU-UHFFFAOYSA-N checkY

    6-(2-Aminopropyl)indole (6-API, 6-IT) is an indole derivative which was first identified being sold on the designer drug market by a laboratory in the Czechia in July 2016.[2]

    Alexander Shulgin says in his book TiHKAL "From the normal 3-position to the 2, the 4, the 5, the 6 or the 7-positions. All five alpha-methyltryptamine isomers are known, but only one is known to be active in man as a CNS active material. This is the 5-isomer, 5-(2-aminopropyl)indole or 5-IT"[1].

    Studies in dogs have also shown the drug to increase hemoglobin levels in the bloodstream.[3]

    Legality[edit]

    References[edit]

    1. ^ a b "New Psychoactive Substances Act (Neue-psychoaktive-Stoffe-Gesetz) (NpSG) Non-official translation" (PDF). Retrieved 9 November 2021.
  • ^ Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA
  • ^ Maxwell GM (September 1964). "The effects of an indole derivative 692'-amino-propyl indole) on the general and coronary haemodynamics of the intact dog". Experientia. 20 (9): 526–7. doi:10.1007/BF02154095. PMID 5856353. S2CID 7574163.
  • ^ "Temporary class drug order report on 5-6APB and NBOMe compounds". UK Home Office. 4 Jun 2013. Retrieved 2013-07-11.
  • ^ UK Home Office (2014-03-05). "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Government. Retrieved 2014-03-11.
  • ^ "Criminal Code Act 1995" (PDF). Australian Government. 2009-08-05. Retrieved 2012-02-08. PAGE 503

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=6-(2-Aminopropyl)indole&oldid=1179018508"

    Categories: 
    Indoles
    Stimulants
    Entactogens and empathogens
    Substituted amphetamines
    Hidden categories: 
    Articles with short description
    Short description matches Wikidata
    Drugs with non-standard legal status
    Wikipedia articles needing clarification from November 2021
    All articles with unsourced statements
    Articles with unsourced statements from November 2021
    Articles without EBI source
    Chemical pages without DrugBank identifier
    Articles without KEGG source
    Drugs missing an ATC code
    Articles containing unverified chemical infoboxes
     



    This page was last edited on 7 October 2023, at 09:34 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki